PL373390A1 - Pochodne kwasu cynamonowego - Google Patents
Pochodne kwasu cynamonowegoInfo
- Publication number
- PL373390A1 PL373390A1 PL03373390A PL37339003A PL373390A1 PL 373390 A1 PL373390 A1 PL 373390A1 PL 03373390 A PL03373390 A PL 03373390A PL 37339003 A PL37339003 A PL 37339003A PL 373390 A1 PL373390 A1 PL 373390A1
- Authority
- PL
- Poland
- Prior art keywords
- cinnamide derivatives
- cinnamide
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02015583 | 2002-07-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL373390A1 true PL373390A1 (pl) | 2005-08-22 |
Family
ID=30011071
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL03373390A PL373390A1 (pl) | 2002-07-15 | 2003-07-07 | Pochodne kwasu cynamonowego |
Country Status (20)
Country | Link |
---|---|
US (1) | US6900354B2 (pl) |
EP (1) | EP1523469B1 (pl) |
JP (1) | JP4108679B2 (pl) |
KR (1) | KR20050029206A (pl) |
CN (1) | CN1305838C (pl) |
AR (1) | AR040489A1 (pl) |
AT (1) | ATE410407T1 (pl) |
AU (1) | AU2003281030B2 (pl) |
BR (1) | BR0312658A (pl) |
CA (1) | CA2493372A1 (pl) |
DE (1) | DE60323981D1 (pl) |
ES (1) | ES2314219T3 (pl) |
MX (1) | MXPA05000583A (pl) |
PA (1) | PA8577201A1 (pl) |
PE (1) | PE20040667A1 (pl) |
PL (1) | PL373390A1 (pl) |
RU (1) | RU2318802C2 (pl) |
TW (1) | TW200404760A (pl) |
UY (1) | UY27894A1 (pl) |
WO (1) | WO2004007429A1 (pl) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1588704A1 (en) * | 2004-04-22 | 2005-10-26 | Newron Pharmaceuticals S.p.A. | Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders |
KR101128065B1 (ko) | 2004-05-26 | 2012-04-12 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 신나미드 화합물 |
AU2005297966B2 (en) * | 2004-10-26 | 2010-12-23 | Eisai R & D Management Co., Ltd. | Amorphous object of cinnamide compound |
UA90708C2 (ru) | 2005-02-25 | 2010-05-25 | Ф. Хоффманн-Ля Рош Аг | Таблетки с улучшенной дисперсностью лекарственного вещества |
WO2006127133A2 (en) | 2005-04-01 | 2006-11-30 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
WO2007008963A1 (en) * | 2005-07-13 | 2007-01-18 | Jenrin Discovery | Mao-b inhibitors useful for treating obesity |
PL209602B1 (pl) | 2005-10-20 | 2011-09-30 | Inst Chemii Bioorg Pan | Sposób otrzymywania amidu kwasu 3-(4-hydroksyfenylo)propanowego |
WO2007058305A1 (ja) * | 2005-11-18 | 2007-05-24 | Eisai R & D Management Co., Ltd. | シンナミド誘導体の製造方法 |
WO2007058304A1 (ja) * | 2005-11-18 | 2007-05-24 | Eisai R & D Management Co., Ltd. | シンナミド化合物の塩またはそれらの溶媒和物 |
TWI370130B (en) * | 2005-11-24 | 2012-08-11 | Eisai R&D Man Co Ltd | Two cyclic cinnamide compound |
CN101312965B (zh) * | 2005-11-24 | 2011-07-20 | 卫材R&D管理有限公司 | 吗啉型肉桂酰胺化合物 |
NZ568050A (en) | 2005-11-24 | 2010-09-30 | Eisai R&D Man Co Ltd | Morpholine type cinnamide compound |
TWI378091B (en) | 2006-03-09 | 2012-12-01 | Eisai R&D Man Co Ltd | Multi-cyclic cinnamide derivatives |
SA07280403B1 (ar) * | 2006-07-28 | 2010-12-01 | إيساي أر أند دي منجمنت كو. ليمتد | ملح رباعي لمركب سيناميد |
TW200848054A (en) * | 2007-02-28 | 2008-12-16 | Eisai R&D Man Co Ltd | Two cyclic oxomorpholine derivatives |
JPWO2008140111A1 (ja) * | 2007-05-16 | 2010-08-05 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | シンナミド誘導体のワンポット製造方法 |
US7986144B2 (en) * | 2007-07-26 | 2011-07-26 | Schlumberger Technology Corporation | Sensor and insulation layer structure for well logging instruments |
US7935815B2 (en) * | 2007-08-31 | 2011-05-03 | Eisai R&D Management Co., Ltd. | Imidazoyl pyridine compounds and salts thereof |
MX2010002098A (es) | 2007-08-31 | 2010-03-30 | Eisai R&D Man Co Ltd | Compuesto policiclico. |
CA2712095A1 (en) * | 2008-01-28 | 2009-08-06 | Eisai R&D Management Co., Ltd. | Crystalline cinnamide compounds or salts thereof |
NL2005655A (en) | 2009-12-09 | 2011-06-14 | Asml Netherlands Bv | A lithographic apparatus and a device manufacturing method. |
CN104030941B (zh) * | 2014-06-23 | 2016-04-27 | 常州大学 | 一种3-(4-羟基苯基)丙酰胺的合成方法 |
CN107011313B (zh) * | 2016-01-27 | 2021-11-30 | 天士力医药集团股份有限公司 | 取代桂皮酰胺衍生物在制备抗焦虑药物中的应用 |
US11173136B2 (en) | 2018-01-10 | 2021-11-16 | Brightseed, Inc. | Method for modulating metabolism |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2645019A1 (pl) * | 1989-03-30 | 1990-10-05 | Fournier Innovation Synergie | |
US5679715A (en) | 1995-06-07 | 1997-10-21 | Harris; Richard Y. | Method for treating multiple sclerosis |
WO1997033572A1 (en) | 1996-03-15 | 1997-09-18 | Somerset Pharmaceuticals, Inc. | Method for preventing and treating peripheral neurophathy by administering selegiline |
WO2001034172A2 (en) | 1999-11-05 | 2001-05-17 | Vela Pharmaceuticals Inc. | Methods and compositions for treating reward deficiency syndrome |
-
2003
- 2003-07-03 US US10/613,785 patent/US6900354B2/en not_active Expired - Fee Related
- 2003-07-07 CN CNB038160579A patent/CN1305838C/zh not_active Expired - Fee Related
- 2003-07-07 JP JP2004520497A patent/JP4108679B2/ja not_active Expired - Fee Related
- 2003-07-07 BR BR0312658-7A patent/BR0312658A/pt not_active IP Right Cessation
- 2003-07-07 EP EP03740425A patent/EP1523469B1/en not_active Expired - Lifetime
- 2003-07-07 KR KR1020057000637A patent/KR20050029206A/ko not_active Application Discontinuation
- 2003-07-07 RU RU2005104104/04A patent/RU2318802C2/ru not_active IP Right Cessation
- 2003-07-07 PL PL03373390A patent/PL373390A1/pl unknown
- 2003-07-07 AU AU2003281030A patent/AU2003281030B2/en not_active Ceased
- 2003-07-07 WO PCT/EP2003/007231 patent/WO2004007429A1/en active Application Filing
- 2003-07-07 AT AT03740425T patent/ATE410407T1/de not_active IP Right Cessation
- 2003-07-07 MX MXPA05000583A patent/MXPA05000583A/es active IP Right Grant
- 2003-07-07 DE DE60323981T patent/DE60323981D1/de not_active Expired - Fee Related
- 2003-07-07 ES ES03740425T patent/ES2314219T3/es not_active Expired - Lifetime
- 2003-07-07 CA CA002493372A patent/CA2493372A1/en not_active Abandoned
- 2003-07-10 PA PA20038577201A patent/PA8577201A1/es unknown
- 2003-07-11 AR AR20030102502A patent/AR040489A1/es not_active Application Discontinuation
- 2003-07-14 UY UY27894A patent/UY27894A1/es not_active Application Discontinuation
- 2003-07-15 PE PE2003000706A patent/PE20040667A1/es not_active Application Discontinuation
- 2003-07-15 TW TW092119275A patent/TW200404760A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CA2493372A1 (en) | 2004-01-22 |
BR0312658A (pt) | 2005-04-26 |
DE60323981D1 (de) | 2008-11-20 |
RU2005104104A (ru) | 2005-10-10 |
KR20050029206A (ko) | 2005-03-24 |
CN1305838C (zh) | 2007-03-21 |
PE20040667A1 (es) | 2004-09-25 |
WO2004007429A1 (en) | 2004-01-22 |
AR040489A1 (es) | 2005-04-06 |
UY27894A1 (es) | 2003-12-31 |
RU2318802C2 (ru) | 2008-03-10 |
EP1523469B1 (en) | 2008-10-08 |
PA8577201A1 (es) | 2004-02-07 |
JP4108679B2 (ja) | 2008-06-25 |
US20040034096A1 (en) | 2004-02-19 |
TW200404760A (en) | 2004-04-01 |
JP2005533092A (ja) | 2005-11-04 |
AU2003281030B2 (en) | 2009-05-28 |
US6900354B2 (en) | 2005-05-31 |
ATE410407T1 (de) | 2008-10-15 |
EP1523469A1 (en) | 2005-04-20 |
CN1665774A (zh) | 2005-09-07 |
ES2314219T3 (es) | 2009-03-16 |
MXPA05000583A (es) | 2005-04-19 |
AU2003281030A1 (en) | 2004-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP1850A (en) | Spiroindolineplperidine derivatives | |
EG24050A (en) | Heterocylocarboxamide derivatives | |
HK1077068A1 (en) | Azolidinone-vinyl fused-benzene derivatives | |
IL166121A0 (en) | Indole-3-sulphur derivatives | |
EP1522540A4 (en) | AZAARENE DERIVATIVES | |
PL376475A1 (pl) | Pochodne N-podstawionej 2-oksodihydropirydyny | |
GB0230045D0 (en) | Compounds | |
ZA200500471B (en) | N-biarylmethyl aminocycloalkanecarboxamide derivatives | |
PL373390A1 (pl) | Pochodne kwasu cynamonowego | |
EP1558585A4 (en) | NEUROLOGICALLY ACTIVE COMPOUNDS | |
GB0200283D0 (en) | Compounds | |
AU2003222659A8 (en) | 23-o-substituted 5-o-mycaminosyltylonide derivatives | |
AU2003216859A8 (en) | Amidoacetonitrile compounds | |
EP1531854A4 (en) | O-DERIVATED NOCATHIACIN DERIVATIVES | |
GB0213488D0 (en) | 2-Naphthamide derivatives | |
GB0203778D0 (en) | Compounds | |
AU2003243397A8 (en) | Homo-camptothecin derivatives | |
AU2003275480A8 (en) | Compounds | |
GB0221143D0 (en) | Dihydropyridinone derivatives | |
AU2003285777A8 (en) | 3-substituted-4-pyrimidone derivatives | |
GB0210512D0 (en) | Tetrahydro-napthalene derivatives | |
GB0202025D0 (en) | Compounds | |
GB0203807D0 (en) | Compounds | |
GB0213119D0 (en) | Compounds | |
GB0217755D0 (en) | Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |